Skip to main content
. 2021 Apr 3;12(10):1598–1604. doi: 10.1111/1759-7714.13957

FIGURE 1.

FIGURE 1

(a) Progression‐free survival (PFS) of 60 patients treated with afatinib and (b) PFS according to the final dose of afatinib